Regeneron starts two trials of two-antibody antiviral cocktail for Covid-19

The company plans to test REGN-COV2 – consisting of the SARS-CoV-2-specific antibodies REGN10933 and REGN10987 – in four populations, including infected patients and uninfected people at high risk of infection.

Leave a Reply